![](/img/cover-not-exists.png)
Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder
Philip Hazell, Shuyu Zhang, Tomasz Wolańczyk, Joanne Barton, Mats Johnson, Alessandro Zuddas, Marina Danckaerts, Andrula Ladikos, David Benn, Roni Yoran-Hegesh, Pal Zeiner, David MichelsonVolume:
15
Language:
english
Pages:
6
DOI:
10.1007/s00787-006-0506-y
Date:
March, 2006
File:
PDF, 239 KB
english, 2006